Clinical Trial Update: Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating palliative radiotherapy for liver metastases and hepatocellular carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Metastasis
• Hepatocellular Carcinoma

Snippet

Sponsor: University Health Network, Toronto | Conditions: Hepatocellular Carcinoma, Hepatic Metastasis | Phase 2 | Status: COMPLETED